Beyond Buds

What Beyond Buds does

Beyond Buds is a privately held South African medicinal cannabis cultivator headquartered in Montagu, Western Cape. The company operates a Hybrid Indoor Grow House (HIGH) system spanning six grow houses (1,000 sqm / 65,000 sq ft) and a 1,500 sqm mother/clone nursery, supported by a 2MW on-site solar farm. It is fully licensed by SAHPRA and certified to GMP and GACP standards, producing pharmaceutical-grade cannabis flower from 20+ proprietary in-house cultivars with THC levels ranging from 21% to 27%+.

The company's core technology stack combines tissue culture propagation, HVAC/HEPA/HIBO biosecurity filtration, supplemental LED lighting, and GMP-certified post-harvest processing (drying, curing, trimming, packing) to deliver consistent AAA-Grade indoor quality. Its 20+ cultivars include named strains such as Mandarin Cookies (25%+ THC), Jungle Pie (26%+ THC), Full Gas Cookies (27%+ THC), and others, each with documented cannabinoid and terpene profiles. The operation is family-owned, with founding partners whose personal experiences with MS and cancer motivated the venture, supported by 30+ years of prior relationships.

Beyond Buds operates a pure B2B model with no retail or consumer-facing sale. Revenue is generated through one-time sales of pharmaceutical-grade flower to licensed medical cannabis distributors exporting into Europe and the UK, with additional direct relationships to licensed medical professionals and research institutions in South Africa. Pricing is not publicly disclosed and is negotiated per partnership based on volume, strain, and terms. Marketing is minimal and compliance-led, relying on the professional website (beyondbuds.co.za), a partner portal, and direct outreach via the named contact, Roy Ingle.

Name

Beyond Buds

Legal name

Beyond Buds South Africa

Website

https://beyondbuds.co.za

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Beyond Buds is a South African, SAHPRA-licensed and GMP/GACP-certified cultivator of pharmaceutical-grade medicinal cannabis, operating a hybrid indoor facility in Montagu and exporting 20+ proprietary cultivars to licensed medical distributors in Europe and the UK.

Ownership category

akta.pro rank

Headquarters

HQ city

Montagu

HQ country

South Africa

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Infrastructure, Personnel, Technology or R&D

Revenue model

1. Medicinal Cannabis Product Sales: Sale of pharmaceutical-grade medicinal cannabis flower products to licensed distributors and medical partners. The company cultivates over 20 in-house cultivars with THC levels ranging from 21-27%+, positioning products in the premium AAA-Grade quality tier for medical and therapeutic use.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Beyond Buds cultivates and sells pharmaceutical-grade medicinal cannabis flower products grown from more than 20 proprietary in-house hybrid cultivars. Operating from a 1,000 sqm hybrid indoor cultivation facility in Montagu, Western Cape, the company produces consistent AAA-Grade indoor-quality cannabis with THC levels of 21-27%+ and supplies licensed distributors, medical professionals, and research institutions in Europe, the UK, and South Africa under SAHPRA licensing and GMP/GACP certification.

Product overview

Beyond Buds is a South African company cultivating premium medicinal cannabis, offering more than 20 in-house cultivars (strains) with varying chemical (cannabinoid and terpene) profiles. The product portfolio consists of hybrid cannabis cultivars with THC levels ranging from 21% to 27%, including named strains such as Mandarin Cookies, Jungle Pie, Full Gas Cookies, BuBBalooch, Nitro Sunset, Dirty Zest, White Fire Cake, Sunset Sherbet, Keisie Valley Cheese, Gooseberry Pie, and Tangie Bliss. All cultivars are cultivated to pharmaceutical-grade standards ensuring consistent AAA-Grade indoor quality cannabis and therapeutic efficacy for patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Mandarin Cookies Hybrid medicinal cannabis cultivar with 25%+ THC content, heritage of Girl Scout Cookies x Mandarin Sunset. Dominant terpenes include Limonene, Beta-Caryophyllene, Linalool, Myrcene, and Humulene. Cultivated to pharmaceutical-grade AAA-Grade indoor quality for licensed distributors and medical partners.
• Jungle Pie Hybrid medicinal cannabis cultivar with 26%+ THC content, heritage of Jungle Cake x Wedding Pie. Dominant terpenes include Caryophyllene, Limonene, Myrcene, Pinene, and Humulene. Cultivated to pharmaceutical-grade AAA-Grade indoor quality.
• Full Gas Cookies Hybrid medicinal cannabis cultivar with 27%+ THC content, heritage of Ethos Cookies #12 x Mandarin Sunset. Dominant terpenes include Myrcene, Caryophyllene, Limonene, and Humulene. Premium AAA-Grade indoor quality flower.
• BuBBalooch Hybrid medicinal cannabis cultivar with 22%+ THC content, heritage of OG Kush x Looch Sunset (Mandarin Cookies x Sunset Sherbet). Dominant terpenes include Limonene, Caryophyllene, Linalool, and Myrcene.
• Nitro Sunset Hybrid medicinal cannabis cultivar with 25%+ THC content, heritage of Mandarin Cookies #4 RBX. Dominant terpenes include Limonene, Beta-Caryophyllene, Linalool, Beta-Pinene, and Humulene.
• Dirty Zest Hybrid medicinal cannabis cultivar with 23%+ THC content, heritage of GSC x Orange Tangie. Dominant terpenes include Limonene, Beta-Caryophyllene, Myrcene, Linalool, and Humulene.
• White Fire Cake Hybrid medicinal cannabis cultivar with 25%+ THC content, heritage of White Fire OG x Wedding Cake. Dominant terpenes include Caryophyllene, Limonene, Myrcene, and Humulene.
• Sunset Sherbet Hybrid medicinal cannabis cultivar with 22%+ THC content, heritage of Girl Scout Cookies x Pink Panties. Dominant terpenes include Caryophyllene, Myrcene, Linalool, and Humulene.
• Keisie Valley Cheese Hybrid medicinal cannabis cultivar with 21%+ THC content, heritage of UK Original Cheese x Chemdawg. Dominant terpenes include Caryophyllene, Myrcene, Limonene, and Humulene.
• Gooseberry Pie Hybrid medicinal cannabis cultivar with 25%+ THC content, heritage of Blueberry Kush x Wedding Pie. Dominant terpenes include Myrcene, Caryophyllene, Limonene, and Linalool.
• Tangie Bliss Hybrid medicinal cannabis cultivar with 22%+ THC content, heritage of Tangie x White Fire OG. Dominant terpenes include Limonene, Beta-Caryophyllene, Myrcene, Linalool, and Humulene.

Quantifiable outcome

• 20+ proprietary in-house cultivars with THC levels ranging from 21-27%+
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Top Medical Cannabis Distributors in Europe and UKcoreChannel Partner/ Reseller/ DistributorBeyond Buds maintains strategic partnerships with leading medical cannabis distributors in Europe and the UK. These partnerships enable global distribution of their pharmaceutical-grade medicinal cannabis products. The distributors are positioned to deliver Beyond Buds' consistent AAA-Grade quality products to patients across international markets.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Regional players

• IM Cannabis: Israel-headquartered medicinal cannabis company with distribution across Germany and other European markets. Comparable in operating an EU-facing medicinal cannabis business built on imported flower from multiple source jurisdictions.
• Khiron Life Sciences: Colombia-based cannabis producer with EU-focused distribution and a focus on pharmaceutical-grade medicinal cannabis. Operates from a low-cost Latin American production jurisdiction into the same European markets as Beyond Buds.

Broad incumbents

• Aurora Cannabis: Canadian licensed producer with EU GMP-certified facilities and established medicinal cannabis sales across Europe and the UK. Competes with Beyond Buds for the same hospital, pharmacy, and distributor channels.
• OrganiGram Holdings: Canadian licensed producer with EU GMP-certified production and international medical cannabis sales. Competes for the same European pharmaceutical-grade flower demand as Beyond Buds.
• Canopy Growth: Major Canadian LP with global medicinal cannabis operations, including EU GMP-certified facilities and established UK/European distribution. Broad incumbent active in the same pharmaceutical-grade medicinal flower category.
• Cronos Group: Canadian LP with a global medicinal cannabis footprint and established international distribution. A broad incumbent active in the same EU/UK pharmaceutical-grade flower market.
• Tilray Brands: One of the largest global cannabis companies, with significant medicinal cannabis cultivation, EU GMP-certified production, and distribution into Germany, the UK, and other European markets. A broad incumbent with overlapping product categories and export destinations as Beyond Buds.

Direct peers

• Clever Leaves: Colombia-based GMP-certified medicinal cannabis cultivator with a multi-country LatAm production footprint and established EU/UK distribution. Closest functional analogue to Beyond Buds' pharmaceutical-grade, low-cost-jurisdiction, EU-focused B2B export model.

Emerging players

• MediPharm Labs: GMP-certified cannabis producer focused on downstream cannabis derivatives and international B2B supply. Comparable in operating a GMP-certified, export-oriented, B2B-focused cannabis production model.
• Strainz Inc. US-based cannabis brand and distribution platform with a focus on multi-state and international partnerships. Comparable as a B2B distribution intermediary that aggregates supply for licensed dispensaries and partners.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/beyond-buds

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beyond Buds